Loading clinical trials...
Loading clinical trials...
The proposed study will examine the implementation of a Human Papillomavirus (HPV) self-sampling intervention for unscreened and under-screened transgender men and transmasculine individuals living in South Florida. The study will enroll participants to receive this cervical cancer screening intervention in community venues. The purpose of this study is to pilot the self-sampler for feasibility and acceptability within this underserved population.
Age
25 - 65 years
Sex
FEMALE
Healthy Volunteers
Yes
University of Miami
Miami, Florida, United States
Start Date
May 12, 2018
Primary Completion Date
October 17, 2018
Completion Date
October 17, 2018
Last Updated
May 3, 2019
10
ACTUAL participants
HPV self-sampling
BEHAVIORAL
Lead Sponsor
University of Miami
NCT07181278
NCT07451340
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions